Recombinant
RabMAb

Anti-CD99 antibody [EPR3097Y] (ab75858)

Publishing research using ab75858? Please let us know so that we can cite the reference in this datasheet.

ab75858 has been referenced in 1 publication.

  • Chung SS  et al. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Sci Transl Med 9:N/A (2017). WB ; Human . PubMed: 28123069

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up